Miami, Florida
Cancer clinical trials in Miami, FL
200 cancer studies are recruiting participants at sites in Miami as of November 16, 2026, according to ClinicalTrials.gov. Oncology Research Hub can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Miami at a glance
- 200 studies are recruiting at a site in Miami.
- By phase: Early Phase 1 (1), Phase 1 (21), Phase 1/2 (26), Phase 2 (54), Phase 2/3 (4), Phase 3 (53), Phase 4 (5), No phase (23), Observational (13). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (96), university, hospital or other (88), government (16).
- By research area: Lymphoma (60), Breast Cancer (49), Lung Cancer (43), Prostate Cancer (24), Pancreatic Cancer (14), Melanoma (10).
- Most recent update to one of these records: November 16, 2026.
Breast cancer studies recruiting in Miami
Basic details from each study's public record (the 30 most recently updated of 200). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- LeonaBio
- Study site
- Miami Cancer Institute
- Registry record
- NCT05696626 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Miami Cancer Institute
- Registry record
- NCT07488676 · updated
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT03606967 · updated
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Phase 2
- All ages
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT05564377 · updated
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- Phase 1
- Ages 18 to 55
- Female participants
- Sponsor
- TerSera Therapeutics LLC
- Study site
- Regis Clinical Research
- Registry record
- NCT07310420 · updated
A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
- Phase 4
- Ages 18 and older
- All sexes
- Sponsor
- Jonsson Comprehensive Cancer Center
- Study site
- University of Miami Health System
- Registry record
- NCT06934239 · updated
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- ALX Oncology Inc.
- Study site
- Sylvester Comprehensive Cancer Center
- Registry record
- NCT07007559 · updated
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Phase 3
- Ages 18 to 60
- Female participants
- Sponsor
- NRG Oncology
- Study sites
- Miami Cancer Institute · UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT05879926 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Miami, FL on ClinicalTrials.gov.
Lung cancer studies recruiting in Miami
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Phase 3
- Ages 18 to 100
- All sexes
- Sponsor
- Amgen
- Study site
- Regis Clinical Research LLC
- Registry record
- NCT05920356 · updated
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT04665739 · updated
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Phase 3
- Ages 70 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT06096844 · updated
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Miami Cancer Institute
- Registry record
- NCT06498635 · updated
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- No phase
- Ages 50 to 80
- All sexes
- Sponsor
- bioAffinity Technologies Inc.
- Study site
- Miami VA Healthcare System
- Registry record
- NCT07168993 · updated
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- Total Health and Research Center
- Registry record
- NCT07625644 · updated
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT07099898 · updated
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Miami Cancer Institute at Baptist Health, Inc. ( Site 0214)
- Registry record
- NCT06623422 · updated
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Sylvester Comprehensive Cancer Center
- Registry record
- NCT06793215 · updated
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Miami Cancer Institute at Baptist Health, Inc.
- Registry record
- NCT06119581 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Miami, FL on ClinicalTrials.gov.
Prostate cancer studies recruiting in Miami
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 0051)
- Registry record
- NCT06136624 · updated
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- No phase
- Ages 18 and older
- Male participants
- Sponsor
- Axonics, Inc.
- Study site
- University of Miami
- Registry record
- NCT06511141 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Miami, FL on ClinicalTrials.gov.
Lymphoma studies recruiting in Miami
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Mount Sinai Comprehensive Cancer Center
- Registry record
- NCT06806033 · updated
A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma
- Phase 3
- Ages 21 and older
- All sexes
- Sponsor
- Aldeyra Therapeutics, Inc.
- Study site
- Bascom Palmer Eye Institute
- Registry record
- NCT07402876 · updated
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT04840602 · updated
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- Phase 3
- Ages 5 to 60
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Nicklaus Children's Hospital
- Registry record
- NCT05675410 · updated
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT06337318 · updated
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study site
- University of Miami
- Registry record
- NCT03618550 · updated
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Nuvalent Inc.
- Study site
- University of Miami; Sylvester Cancer Center
- Registry record
- NCT05384626 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Miami, FL on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Miami
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Incyte Corporation
- Study site
- Investigative Site US075
- Registry record
- NCT07522073 · updated
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study sites
- UM Sylvester Comprehensive Cancer Center at Kendall · University of Miami Miller School of Medicine-Sylvester Cancer Center
- Registry record
- NCT04858334 · updated
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Immuneering Corporation
- Study site
- Miami Cancer Institute
- Registry record
- NCT07562152 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Miami, FL on ClinicalTrials.gov.
Ask about studies near Miami
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
706 studies recruiting across 90 cities.
Tampa
217 studies recruiting.
Jacksonville
189 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections